Short description
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Description
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Rockville, Maryland, United States, North America
Founded on
January 1, 2011
Exited on
November 13, 2015
Went public on
November 13, 2015
Stock symbol
AVTX
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Nopepepe, Cannot Access, Absolutely Noaccess, Noaccess, Uh Ohhhh, Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Isaac Blech